logo
Inching closer to top of waste pile

Inching closer to top of waste pile

Time of India28-04-2025

Central Pollution Control Board
Biomedical Waste Treatment Facilities
Karnataka State Pollution Control Board
Karnataka has jumped to the second position in biomedical waste production in the country, a report by the(CPCB) has highlighted. The state is now generating 76 tonnes per day of biomedical waste, only next to Uttar Pradesh (91 tonnes per day).However, there is no gap in the generation and treatment of biomedical waste in Karnataka anymore. The report suggests that all the waste being generated under this category is being treated through Common(CBWTFs), incinerators, and deep burial pits.It also raises concerns about deep burial pits being used to dispose of biomedical waste. In Karnataka, as many as 1,581 healthcare facilities are utilising deep burial pits to treat this category of waste.In deep burial, biomedical waste is placed in a pit or trench and then covered with soil and lime. As per the Bio-medical Waste Management Rule (BMW) 2016, certain types of biomedical waste, such as human and animal anatomical waste and soiled waste, can be disposed of through deep burial where there is no access to CBWTF. Moreover, deep burial is permitted only in rural or remote areas where there is no access to CBWTF and carried out with prior approval from the prescribed authority, i.e., State Pollution Control Board, following standards prescribed under BMWM Rules.Experts say that if deep burial sites are not properly managed, they may lead to environmental pollution, including contamination of groundwater.'These sites should be leak-proof and should not be dug in areas with shallow aquifers. They should also be away from residential areas and located to ensure that no contamination occurs to surface water or groundwater. If not made watertight, it will contaminate groundwater sources. This system of disposing of biomedical waste is risky,' said a waste management expert.As per BMW rules too, the location of the deep burial site shall be authorised by the prescribed authority. Moreover, the groundwater table level should be a minimum of six metre below the lower level of the deep burial pit. Experts say that theshould ensure that treatment facilities are established even in remote areas, so deep burials of biomedical waste can be avoided.In Karnataka, 28 districts are currently covered by CBWTF. Belagavi, Haveri, and Kodagu still lack this facility.The CPCB report has also underlined that Karnataka currently has 54,594 healthcare facilities, and while 48,320 are authorised, 6,274 facilities are operating without authorisation. Moreover, 7,910 violations of BMWM Rules, 2016 were recorded in Karnataka in 2024, and notices were issued to 6,697 defaulting healthcare facilities.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Central Pollution Control Board to decide on future of flue gas desulphurisation units: Power Minister
Central Pollution Control Board to decide on future of flue gas desulphurisation units: Power Minister

The Hindu

time13 hours ago

  • The Hindu

Central Pollution Control Board to decide on future of flue gas desulphurisation units: Power Minister

The Union Ministry of Power will wait for the Central Pollution Control Board (CPCB) to decide on whether flue gas desulphurisation (FGD) units should be mandatory for all coal-fired thermal power plants, Union Power Minister Manohar Lal Khattar said in a response to a question from The Hindu at a press conference on Tuesday (June 10, 2025). On the June 4, The Hindu had reported on a meeting in April involving a high-powered committee of experts, chaired by the Principal Scientific Advisor, Ajay Sood. The group recommended that India do away with its decade-long policy of mandating equipment, including FGD units, in all coal-fired thermal power plant units (TPPs). While 92% of India's 600 TPPs, spread across about 180 coal plants, haven't yet installed FGD units, the recommendation exempts about 80% of them from installing such equipment. So far, the government has granted three extensions since 2017, the latest being in December 2024, for plants to comply by 2027-2030. FGDs are an additional piece of equipment required to be retro-fitted in TPPs to cut harmful sulphur dioxide emissions resulting from burning coal. Sulphur dioxide emissions can also hover in the atmosphere and form aerosols of sulphates that, on the one hand, can somewhat temper the heat from global warming, but also exacerbate particulate matter pollution and respiratory diseases. It is estimated that the current installation cost of such equipment is about ₹1 crore per megawatt (MW) of installed power capacity. 'Scientific institutions such as CSIR (Council of Scientific and Industrial Research), IIT (Indian Institute of Technology) Delhi have studied this. The sulphate aerosols from these coal plants aren't to the extent that they affect human is less than 5%. On the contrary, it is necessary that some of it remain in the atmosphere. If it is too less, it can increase warming,' Mr. Khattar said. 'That said, the CPCB is looking at this and hasn't come to a conclusion. We will implement anything only after examining their verdict. About 97,000 MW of power will be added, and implementing FGD means an additional expense of ₹97,000 crore. We have to consider this carefully. Neither should health be harmed, nor people face increased tariffs, nor warming increase. You must have read about the thousands of lives lost in Europe from heatwaves,' he added. As The Hindu had reported, the committee, according to the minutes of the meeting viewed by The Hindu, will 'recommend' to the Power and Environment Ministers that only power plants located in a 10 km radius of the National Capital Region, and cities with a population of over one million, are required to install FGD units. These are called Category A plants. There are 66 such plants, and only 14 of them have installed FGD units. All these plants are required to comply by 2027. Those in a 10-km radius of 'Critically Polluted Cities' or 'Non Attainment Cities', called Category B plants, would be eligible for exemption on a 'case by case' basis, upon a joint review by the Central Electricity Authority or the CPCB. There are 72 such plants, with only 4 having installed FGD units. These plants have a deadline of 2028. The remaining 462 plants come under Category C. Thirty-two of them have installed FGD units. These plants have a 2029 deadline. Over 600 units in categories A and B could be additionally exempted if they were 20 years and older. 'The key common point in these studies is that, fitment of FGDs in all TPPs in India is not necessary to comply with the NAAQ (National Ambient Air Quality) standards whose compliance is essential to safeguard public health. While all TPPs must comply with the December 2015 stack emission standards for PM pollution and freshwater consumption, the SO2 stack emission standards can be relaxed to ensure that they are in conformance with the NAAQ standards which are notified by CPCB, keeping in mind the human health and other aspects. This way, TPPs may be able to comply with these standards without fitting FGDs. Since the existing NAAQ standards (for ambient SO2) must be complied with, this change will not affect human health in India,' the committee had concluded.

Experts meet to boost monoclonal antibody innovation in India
Experts meet to boost monoclonal antibody innovation in India

United News of India

time18 hours ago

  • United News of India

Experts meet to boost monoclonal antibody innovation in India

New Delhi, June 10 (UNI) Leading voices from the pharmaceutical industry, biotech start-ups, funding agencies such as BIRAC, and premier academic institutions convened on Tuesday to explore new strategies for accelerating monoclonal antibody (mAb) therapies in India. Such a therapy uses antibodies, made in a lab, to target and treat specific diseases, including cancer. The symposium, organised by the Translational Health Science and Technology Institute (THSTI), highlighted India's rapidly growing biopharmaceutical sector and noted the vast potential for indigenous innovation in the development of mAb therapies—critical tools in precision medicine. A recurring theme throughout the discussions was the need for early and sustained collaboration between academia and industry, particularly at the innovation and discovery stages. Such partnerships, experts agreed, are vital to developing affordable, homegrown technologies that serve national healthcare needs, said a statement from the Union Science and Technology. Prof. Jayanta Bhattacharya, Dean of THSTI, stressed that bridging the gap between scientific research and industrial application is essential to ensure India's self-reliance in biologics. Echoing this, Prof. G. Karthikeyan, Executive Director of THSTI, highlighted the importance of establishing innovation clusters where industry and academia can collaborate closely. These clusters, he said, would also serve as talent hubs, fostering the next generation of skilled professionals. Dr. Alka Sharma, Senior Adviser at the Department of Biotechnology (DBT), outlined the government's Bio-E3 policy (Biotechnology for Economy, Environment & Employment). She reaffirmed DBT's commitment to advancing mAb platforms, which are vital for addressing complex diseases and ensuring equitable access to high-quality biologics. She emphasised that the Bio-E3 initiative aims to build biotech self-reliance, reduce dependency on imports, and strengthen domestic R&D capacity through targeted investments in technologies like mAbs. The symposium served as a dynamic platform for cross-sector dialogue, reinforcing the belief that strategic collaboration and policy support are key to unlocking India's full potential in the global biopharmaceutical landscape, added the statement. UNI AJ SSP

Restore medical treatment of ex-serviceman's dependent under ECHS regardless of PWD Act listing: AFT to MoD
Restore medical treatment of ex-serviceman's dependent under ECHS regardless of PWD Act listing: AFT to MoD

Time of India

time2 days ago

  • Time of India

Restore medical treatment of ex-serviceman's dependent under ECHS regardless of PWD Act listing: AFT to MoD

Chandigarh: The ministry of defence (MoD) cannot deny medical treatment under the Ex-Servicemen Contributory Health Scheme (ECHS) to dependents of a member merely because their ailment is not listed as a disability under the Rights of Persons with Disabilities (PWD) Act, 2016, according to an Armed Forces Tribunal (AFT) ruling. The tribunal also clarified that the authorities are supposed to consider practical as well as compassionate aspects when cancelling or withdrawing any policy or letter and "are under obligation to see that no one is harmed". A division bench comprising Justice Anil Kumar, judicial member, and Vice Admiral Atul Kumar Jain, administration member of AFT Lucknow, passed these orders while allowing an application filed by Sheela Devi, widow of Havildar Ganga Sahay. She sought directions to issue an order to the MoD to continue her son's treatment after a kidney transplant, which was stopped after he turned 25 years, as per a policy letter dated Dec 5, 2017, issued by the ministry of defence (DoESW). The applicant's husband joined the Indian Army in 1974, was discharged from service in 1996, and died in 2003. Thereafter, the applicant was issued an ECHS card, which included all her family members. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Keep Your Home Efficient with This Plug-In elecTrick - Save upto 80% on Power Bill Learn More Undo Her son, Mohit Kumar, was admitted to the Command Hospital, Lucknow, in Aug 2021 and was diagnosed with 'Advanced Renal Dysfunction with Small Echogenic Kidney' and was advised to undergo a kidney transplant. The applicant donated a kidney to her son, which was transplanted on June 14, 2023, and since then, her son has been under treatment through ECHS. However, she was informed by the authorities that her son does not fall under the PWD Act, 2016, and therefore, he is not eligible for further treatment through ECHS beyond the age of 25. Aggrieved by the authorities' decision, she approached the AFT Lucknow. She contended that after her husband's death, she is in a financial crisis as she does not have any other source of income except a meagre family pension. The counsel for the applicant further submitted that her son's disability (chronic kidney disease) being a renal transplant case was permanent in nature and assessed at 80-90%. He also submitted that the treatment could not be stopped on the grounds of the disease not being included in the list of disabilities under the PWD Act, 2016, as he has been under treatment for chronic kidney disease since Aug 2021. Counsel representing the MoD reiterated that the treatment of the applicant's son was stopped as per rules because the kidney disease is not included in the list of 21 disabilities under the PWD Act, 2016, and her son has crossed the permissible age of 25 years. After hearing all the parties, the AFT held that the authorities acted in a very casual manner without considering the fact that he is suffering from a serious kidney ailment that threatens his life. In its detailed order released last week, the AFT further directed the MoD to restore or restart the treatment, considering it as a special case, and to reimburse the expenses incurred by the applicant in the treatment of her son from the date of stoppage of the treatment until its actual restoration.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store